These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1929638)

  • 1. Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine.
    Parenteau GL; Clark RE
    Ann Thorac Surg; 1991 Oct; 52(4):832-8. PubMed ID: 1929638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury.
    Barr ML; Carey JN; Nishanian GP; Roberts RF; Sakamaki Y; Darbinian SH; Starnes VA
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):631-6; discussion 636-7. PubMed ID: 9535451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbit.
    Ball TD; Lundy EF; Zelenock GB; D'Alecy LG
    J Vasc Surg; 1987 Dec; 6(6):572-7. PubMed ID: 3694755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
    Mann JS; Clement P; Sheridan AQ; Soryal I; Fairfax AJ; Holgate ST
    J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
    Reilly FD; Cilento EV; McCuskey RS
    Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute reoxygenation injury in the isolated rat heart: role of resident cardiac mast cells.
    Keller AM; Clancy RM; Barr ML; Marboe CC; Cannon PJ
    Circ Res; 1988 Dec; 63(6):1044-52. PubMed ID: 2848639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
    Watt GD; Bui TC; Bewtra AK; Townley RG
    J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
    Ungerer RG; Tashkin DP; Siegel SC; Deutsch RI
    J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of involvement of mast cell degranulation in the antiarrhythmic effect of preconditioning in rats.
    Humphreys RA; Kane KA; Parratt JR
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):418-23. PubMed ID: 9514187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol and lodoxamide in complement-induced hepatic ischemia.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    J Surg Res; 1988 Jul; 45(1):28-36. PubMed ID: 3260642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lodoxamide tromethamine prevents neutrophil accumulation in reexpansion pulmonary edema.
    Veal CF; Jackson RM; Brannen AL; Fulmer JD
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):227-32. PubMed ID: 2476595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lodoxamide on ischemic reperfused myocardium.
    Jolly SR; Abrams GD; Romson JL; Bailie MB; Lucchesi BR
    J Cardiovasc Pharmacol; 1982; 4(3):441-8. PubMed ID: 6177941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S; Schiavone M; Bonini S; Magrini L; Lischetti P; Lambiase A; Bucci MG
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
    Johnson HG; Sheridan AQ
    Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat.
    Galiñanes M; Mullane KM; Bullough D; Hearse DJ
    Circulation; 1992 Aug; 86(2):598-608. PubMed ID: 1638725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation.
    Ollier S; Graham VA; Bentley S; Davies RJ
    Clin Allergy; 1982 Nov; 12(6):587-94. PubMed ID: 7151268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of oxidative enzymes by anti-allergy drugs.
    White GJ
    Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.